ZAMMSA has announced that it has received 100,000 vials of WHO-prequalified Artesunate 60mg, which will help in the treatment of severe malaria. In a statement, Monday, ZAMMSA Senior Manager for Corporate Communications Bradley Chingobe said the shipment formed part of a K31 million procurement contract, aimed at strengthening the availability of essential antimalarial commodities across the country. He said the latest delivery follows the successful receipt of an earlier consignment of 8,400 vials, bringing the total received so far to over 108,400 vials. “The Zambia Medicines and Medical Supplies Agency (ZAMMSA) is pleased to announce a significant milestone in the national fight against malaria with the arrival of a critical consignment of lifesaving medication. On Friday, July 18, 2025, ZAMMSA...